Drug intelligence / Profile preview

3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the benzophenone class. It is known as a balanol analog and has been studied primarily as an experimental inhibitor of protein kinases. Specifically, it acts as an ATP-site competitive inhibitor of cAMP-dependent protein kinase (protein kinase A), and may also inhibit other related kinases such as serum/glucocorticoid regulated kinase family member SGK3. Its structure is based on modifications of balanol, a natural product known for potent inhibition of serine/threonine kinases[1][6][7][10]. The compound has not been approved for clinical use and remains experimental.

Other names
Balanol analog 8(3R,4R)-3-{3-[(2S)-butan-2-yl]-4-hydroxybenzamido}azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate(3R,4R)-3-{3-[2S)-butan–2–yl]-4–hydroxybenzoyl}amino–azepanyl 4-(2-hydroxy–5-methoxybenzoyl)benzoate
02

Targets

SGK3 (Serum/glucocorticoid regulated kinase family member 3)PKA (Cyclic amp-dependent protein kinase)

Beyond the preview

Go deeper on 3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call